The utility of thiopurine methyltransferase enzyme testing in inflammatory bowel disease

Canadian Journal of Gastroenterology

Volumn 27, Issue 1, 2013, Pages 39-43

  Chisick, Laura ^a   Oleschuk, Curtis ^a   Bernstein, Charles N ^a  

^a UNIVERSITY OF MANITOBA   (Canada)

Author keywords

Crohn disease; Leukopenia; Thiopurine methyltransferase; Thiopurines; Ulcerative colitis

Indexed keywords

AZATHIOPRINE; MERCAPTOPURINE; THIOPURINE METHYLTRANSFERASE;

ADOLESCENT; ADULT; AGED; ARTICLE; CANADA; ENTERITIS; ERYTHROCYTE; FEMALE; HUMAN; LEUKOCYTE COUNT; LEUKOPENIA; MAJOR CLINICAL STUDY; MALE; MEDICAL RECORD REVIEW; PRIORITY JOURNAL; REMISSION; RETROSPECTIVE STUDY; TREATMENT DURATION;

EID: 84872574074     PISSN: 08357900     EISSN: None     Source Type: Journal    
DOI: 10.1155/2013/280860     Document Type: Article

References (18)

1. Khan KJ, Dubinsky MC, Ford AC, Ullman TA, Talley NJ, Moayyedi P. Efficacy of immunosuppresive therapy for inflammatory bowel disease: A systematic review and meta-analysis. Am J Gastroenterol 2011;106:630-42.
2. Prefontaine E, MacDonald J, Sutherland L. Azathiopurine or 6-mercaptopurine for induction of remission in Crohn's disease. Coch Databse Syst Rev 2009;(4):CD000545.
3. Dubinsky M. Azathioprine, 6-mercaptopurine in inflammatory bowel disease: Pharmacology, efficacy, and safety. Clin Gastroenterol Hepatol 2004;2:731-43.
4. Ardizzone S, Maconi G, Russo A, Imbesi V, Colombo E, Bianchi Porro G. Randomized controlled trial of azathioprine and 5-aminosalicylic acid for treatment of steroid dependent ulcerative colitis. Gut 2006;55:47-53.
5. Sandborn W. A review of immune modifier therapy for inflammatory bowel disease: Azathioprine, 6-mercaptopurine, cyclosporine and methotrexate. Am J Gastroenterol 1996;91:423-33.
6. Weinshilboum R, Sladek S. Mercaptopurine pharmacogenetics: Monogenic inheritance of erthyrocyte thiopurine methyltransferase activity. Am J Hum Genet 1980;32:651-62.
7. Yates CR, Krynetski EY, Loennechen T, et al. Molecular diagnosis of thiopurine S-methyltransferase deficiency: Genetic basis for azathioprine and mercaptopurine intolerance. Ann Int Med 1997;126:608-14.
8. Rossi AM, Bianchi M, Guarnieri C, Barale R, Pacifici GM. Genotype-phenotype correlation for thiopurine S-methyltransferase in healthy Italian subjects. Eur J Clin Pharmacol 2001;57:51-4.
9. Ford L, Berg J. Determination of thiopurine S-methyltransferase activity in erythrocytes using 6-thioguanine as substrate and a non-extraction liquid chromatographic technique. J Chromatogr B Analyt Technol Biomed Life Sci 2003;798:111-5.
10. Ford LT, Cooper SC, Lewis MJ, Berg JD. Reference intervals for thiopurine S-methyltransferase activity in red blood cells using 6-thioguanine as substrate and rapid non-extraction liquid chromatography. Ann Clin Biochem 2004;41:303-8.
11. Ford L, Graham V, Berg J. Whole blood thiopurine S-methyltransferase activity with genotype concordance: A new, simplified phenotyping assay. Ann Clin Biochem 2006;43:354-60.
12. Colombel JF, Sandborn WJ, Reinisch W, et al SONIC Study Group. Infliximab, azathioprine, or combination therapy for Crohn's disease. N Engl J Med 2010;362:1383-95.
13. Lichtenstein GR, Abreu MT, Cohen R, Tremaine W; American Gastroenterological Association. American Gastroenterological Association Institute technical review on corticosteroids, immunomodulators, and infliximab in inflammatory bowel disease. Gastroenterology 2006;130:935-9.
14. Gisbert J, Gomollon F. Thiopurine-induced myelotoxicity in patients with inflammatory bowel disease: A review. Am J Gastroenterol 2008;103:1783-800.
15. Chouchana L, et al. Screening of TPMT deficiency by phenotyping and genotyping: A retrospective study among 1,500 IBD patients in France. Gastroenterology 2011;140:S281-2.
16. Weinshilboum R. Thiopurine pharmacogenetics. Clinical and molecular studies of thiopurine methyltransferase. Drug Metab Disp 2001;29:601-5.
17. Pearson DC, May GR, Fick GH, Sutherland LR. Azathioprine and 6-mercaptopurine in Crohn's Disease. A meta-analysis. Ann Intern Med 1995;123:132-42.
18. Gisbert JP, Niño P, Rodrigo L, Cara C, Guijarro LG. Thiopurine methyltransferase (TPMT) activity and adverse effects of azathioprine in inflammatory bowel disease: Long term follow-up study of 394 patients. Am J Gastroenterol 2006;101:2769-76.